We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Certain Blood Types Could Be Associated with Greater Risk of Contracting COVID-19, Confirms New Study

By HospiMedica International staff writers
Posted on 04 Mar 2021
Print article
Illustration
Illustration
As researchers around the world work to identify and address risk factors for severe COVID-19, there is additional evidence that certain blood types could be associated with greater risk of contracting the disease.

The findings of one of the first laboratory studies conducted by researchers at Brigham and Women’s Hospital (Boston, MA, USA) suggest that SARS-CoV-2, the virus that causes COVID-19, is particularly attracted to the blood group A antigen found on respiratory cells. In the study, researchers assessed a protein on the surface of the SARS-CoV-2 virus called the receptor binding domain, or RBD. The RBD is the part of the virus that attaches to the host cells, so it is an important research target for understanding how infection occurs. The team assessed synthetic blood group antigens on respiratory and red blood cells found in blood group A, B, and O individuals, and analyzed how the SARS-CoV-2 RBD interacted with each unique blood type. They discovered that the RBD had a strong preference for binding to blood group A found on respiratory cells. It did not display a preference for blood group A red blood cells, or other blood groups found on respiratory or red cells. The capacity of the RBD to preferentially recognize and attach to the blood type A antigen found in the lungs of blood type A individuals may provide insight into the potential link between blood group A and COVID-19 infection.

Based on their observations, the team sought to determine whether a similar binding preference existed for the RBD of SARS-CoV, the virus that causes severe acute respiratory syndrome (SARS). Although the makeup of the virus differs, the SARS-CoV RBD exhibited the same preference to bind to the group A antigens on respiratory cells. The team has emphasized that their findings alone could not fully describe or predict how coronaviruses like SARS-CoV-2 and SARS-CoV would affect patients of various blood types. While further research is needed to understand that influence, the research adds to findings from earlier studies suggesting a possible link between blood type and COVID-19 susceptibility and severity.

“It is interesting that the viral RBD only really prefers the type of blood group A antigens that are on respiratory cells, which are presumably how the virus is entering most patients and infecting them,” said study author Sean R. Stowell, MD, PhD, of Brigham and Women’s Hospital. “Blood type is a challenge because it is inherited and not something we can change. But if we can better understand how the virus interacts with blood groups in people, we may be able to find new medicines or methods of prevention.”

Related Links:
Brigham and Women’s Hospital

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Ultra Low Floor Level Bed
Solite Pro

Print article

Channels

Critical Care

view channel
Image: A machine learning tool can identify patients with rare, undiagnosed diseases years earlier (Photo courtesy of 123RF)

Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs

Patients suffering from rare diseases often endure extensive delays in receiving accurate diagnoses and treatments, which can lead to unnecessary tests, worsening health, psychological strain, and significant... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more